Alcon (ALC) Non Operating Interest Expenses (2009 - 2026)
Alcon (ALC) posted Non Operating Interest Expenses of -$53.0 million for Q2 2026, down 1.92% on a QoQ basis from -$52.0 million in Q1 2026, and down 3.92% year-over-year from -$55.2 million in Q2 2025.
Analysis
Alcon (ALC) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
Alcon has reported Non Operating Interest Expenses for 11 years, with the latest figure at -$53.0 million in Q2 2026.
- On a quarterly basis, Non Operating Interest Expenses fell 3.92% year-over-year to -$53.0 million in Q2 2026; TTM through Jun 2026 was -$209.0 million, a 5.56% decrease from a year earlier, with the FY2025 full-year figure at -$204.0 million, down 6.25% from the prior year.
- Non Operating Interest Expenses was -$53.0 million for Q2 2026 at Alcon, down from -$52.0 million in the prior quarter.
- The five-year high for Non Operating Interest Expenses was -$29.0 million in Q1 2022, with the low at -$134.0 million in Q4 2022.
- Average Non Operating Interest Expenses over 5 years is -$51.1 million, with a median of -$48.0 million recorded in 2023.
- The largest YoY upside for Non Operating Interest Expenses was 64.93% in 2023 against a maximum downside of 62.07% in 2023.
- Over 5 years, Non Operating Interest Expenses stood at -$134.0 million in 2022, then jumped by 64.93% to -$47.0 million in 2023, then decreased by 2.13% to -$48.0 million in 2024, then dropped by 10.42% to -$53.0 million in 2025, then changed by 0.0% to -$53.0 million in 2026.
- The last three Non Operating Interest Expenses figures came in at -$53.0 million (Q2 2026), -$52.0 million (Q1 2026), and -$53.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.00 Mn |
| Mar 31, 2026 | -52.00 Mn |
| Dec 31, 2025 | -53.00 Mn |
| Sep 30, 2025 | -51.00 Mn |
| Jun 30, 2025 | -51.00 Mn |
| Dec 31, 2024 | -48.00 Mn |
| Sep 30, 2024 | -49.00 Mn |
| Jun 30, 2024 | -50.00 Mn |
| Mar 31, 2024 | -45.00 Mn |
| Dec 31, 2023 | -47.00 Mn |
| Sep 30, 2023 | -47.00 Mn |
| Jun 30, 2023 | -48.00 Mn |
| Mar 31, 2023 | -47.00 Mn |
| Dec 31, 2022 | -134.00 Mn |
| Sep 30, 2022 | -34.00 Mn |
| Jun 30, 2022 | -31.00 Mn |
| Mar 31, 2022 | -29.00 Mn |
| Dec 31, 2021 | -120.00 Mn |
| Sep 30, 2021 | -31.00 Mn |
| Jun 30, 2021 | -30.00 Mn |